Holen Sie sich die Stockscreener-App
351.82
4.96%
16.63
Handel nachbörslich:
351.49
-0.33
-0.09%
Krystal Biotech Inc Aktie (KRYS) Neueste Nachrichten
Krystal Biotech Inc (KRYS) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
TradingKey - TradingKey
Krystal Biotech, Inc. (KRYS) Q1 2024 Earnings ReportResults, Call & Slides - TipRanks
Krystal Biotech, Inc. Revenue Breakdown – NASDAQ:KRYS - TradingView
These 3 Healthcare Stocks Have Crushed the Market This Year. Here's Why There's More Upside Ahead - Yahoo Finance
Krystal Biotech, Inc. (KRYS) Stock Price, News, Quote & History - Yahoo! Finance Canada
KRYS|Krystal Biotech Inc|Price:335.190|Chg%:+7.690 - TradingKey
Krystal Biotech, Inc. (KRYS) stock price, news, quote and history - Yahoo Finance UK
Krystal Biotech Inc (KRYS) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Krystal Biotech, Inc.(NasdaqGS: KRYS) added to S&P 400Biotechnology - marketscreener.com
Krystal Biotech, Inc.(NasdaqGS: KRYS) added to S&P 400 Health Care - marketscreener.com
Krystal Biotech, Inc.(NasdaqGS: KRYS) dropped from S&P 600 Health Care - marketscreener.com
Krystal Biotech, Inc.(NasdaqGS: KRYS) dropped from S&P 600 - marketscreener.com
Krystal Biotech, Inc. (KRYS) Q2 2024 Earnings ReportResults, Call & Slides - TipRanks
Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026 - The Manila Times
Krystal Biotech sets Aug. 3 webcast before U.S. markets open - Stock Titan
Krystal Biotech Reveals Single-Patient Data from Discontinued KB801 Trial in Patent Filing - Kalkine Media
Krystal BiotechFiles Response With Uspto On Kb801 Patent ApplicationSEC Filing - TradingView
Why Tutor Perini Stock Trounced the Market on Tuesday - The Motley Fool
Krystal Biotech, Inc. (KRYS) Q3 2025 Earnings ReportResults, Call & Slides - TipRanks
Krystal Biotech, Inc. (KRYS) Q4 2025 Earnings ReportResults, Call & Slides - TipRanks
Krystal Biotech (KRYS) Joins S&P MidCap 400 Amid Index Changes - GuruFocus
Krystal Biotech, Inc. (KRYS) Q3 2024 Earnings ReportResults, Call & Slides - TipRanks
Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600 - Finansavisen
Krystal Biotech, Inc. (KRYS) Stock Analysis: Exploring a $10 Billion Valuation and Strategic Growth in Genetic Medicine - DirectorsTalk Interviews
(KRYS) and the Role of Price-Sensitive Allocations - Stock Traders Daily
KRYS Jumps As Wall Street Hikes Price Targets On Vyjuvek Momentum - StocksToTrade
KRYS Jumps As Analysts Race To Lift Price Targets - StocksToTrade
KRYS Jumps As Wall Street Lifts Bullish Price Targets - StocksToTrade
Krystal Biotech Rises as Investors Lean on Commercial Momentum and Pipeline Catalysts - Quiver Quantitative
Krystal Biotech (NASDAQ:KRYS) Shows High-Growth Momentum With Perfect Minervini Trend Template Setup - ChartMill
BofA Securities Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $396 - Moomoo
ETFs Investing in Krystal Biotech, Inc. Stocks - TradingView
Krystal Biotech, Inc. Stock 12‑Month Price Target Raised to $369.44, Implies 1% Upside - TradingView
Jefferies Maintains Krystal Biotech(KRYS.US) With Buy Rating, Raises Target Price to $474 - Moomoo
BofA raises Krystal Biotech stock price target on Vyjuvek growth By Investing.com - Investing.com Nigeria
BofA raises Krystal Biotech stock price target on Vyjuvek growth - Investing.com
Krystal Biotech Stock And 2 Biotech Names With Pipeline Catalysts - Sahm
KRYS Stock Rallies On Upbeat Earnings: Jefferies Ups Price Target On Sustained Vyjuvek Optimism - Stocktwits
Is the options market predicting a spike in Krystal Biotech stock? - MSN
Here's why Krystal Biotech, Inc. (KRYS) is a strong momentum stock - MSN
Analysts see more upside for Abivax, Krystal Biotech, Marvell - MSN
3 Soaring Stocks That May Have More Upside Ahead - The Globe and Mail
Krystal Biotech focuses on gene-based dermatology treatments as investors watch long-term growth - ad-hoc-news.de
Krystal Biotech, Inc. (KRYS) Stock Analysis: A High-Potential Biotech with Robust Revenue Growth and Strategic Therapeutic Pipeline - DirectorsTalk Interviews
KRYSKrystal Biotech Inc Options - Finviz
Price to book forward of Krystal Biotech, Inc. – NASDAQ:KRYS - TradingView
Krystal Biotech Inc at TD Cowen Healthcare Conference Transcript - GuruFocus
Krystal Biotech stock soars 16% in three months: Here's why - MSN
Krystal Biotech (KRYS) soars 3.4%: Is further upside left in the stock? - MSN
Krystal Biotech (KRYS) Soars 3.4%: Is Further Upside Left in the Stock? - Yahoo Finance
Krystal Biotech, Inc. (KRYS) Stock Analysis: A Biotech Marvel with 31.9% Revenue Growth and Strong Buy Ratings - DirectorsTalk Interviews
Krystal Biotech, Inc. Actuals & Estimates (NASDAQ:KRYS) - TradingView
Krystal Biotech, Inc. Actuals & Estimates (FWB:4KB) - TradingView
Form 4 Krystal Biotech Inc For: 26 June By Investing.com - Investing.com South Africa
Krystal Biotech, Inc. Actuals & Estimates (MIL:1KRYS) - TradingView
1.97%
0.83%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):